Related Experiment Video

Updated: Jan 5, 2026

Intranasal Administration of CNS Therapeutics to Awake Mice
07:15

Intranasal Administration of CNS Therapeutics to Awake Mice

Published on: April 8, 2013

61.3K

[Is inhalation of hypertonic saline for bronchiolitis effective in infants and toddlers?]

Inge Axelsson1, Sofia Sollander2

  • 1Mittuniversitet - Omvårdnad och medicinsk vetenskap Östersund, Sweden Mittuniversitet - Omvårdnad Östersund, Sweden.

Lakartidningen
|October 23, 2019
PubMed

Insights

Inhalation of hypertonic saline for bronchiolitis in infants offers minimal benefits for moderate cases and unproven advantages for severe cases. Routine use is not recommended due to questionable efficacy and placebo effects.

Area of Science:

  • Pediatrics
  • Respiratory Medicine
  • Evidence-Based Medicine

Background:

  • Early studies suggested benefits of hypertonic saline inhalation for infant bronchiolitis.
  • Subsequent research has raised questions regarding the efficacy of this treatment.

Purpose of the Study:

  • To review current evidence on hypertonic saline inhalation for bronchiolitis.
  • To evaluate the benefits and drawbacks of this intervention in infants and toddlers.

Main Methods:

  • Systematic review of four reviews (2015-2017) and two recent studies.
  • Analysis of treatment outcomes in moderately severe and severe bronchiolitis cases.

Main Results:

  • Benefits of hypertonic saline are small or absent in moderately severe bronchiolitis; routine use is not supported.
  • Potential benefits in severe cases are not definitively proven.
  • The use of saline as a placebo is questionable; a study with a non-inhalation placebo showed no benefit.

Conclusions:

  • Hypertonic saline inhalation should not be a routine treatment for bronchiolitis.
  • Consideration in severe cases may be warranted, but evidence remains inconclusive.
  • Further research with appropriate placebo controls is needed to clarify efficacy.

More Related Videos

Methodology for Sputum Induction and Laboratory Processing13:28

Methodology for Sputum Induction and Laboratory Processing

Published on: December 17, 2017

28.5K
Bronchoalveolar Lavage BAL for Research; Obtaining Adequate Sample Yield11:47

Bronchoalveolar Lavage BAL for Research; Obtaining Adequate Sample Yield

Published on: March 24, 2014

75.0K

Related Concept Videos

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by...
899
Inhaled Medications01:23

Inhaled Medications

Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
674
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
403
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.0K
Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
2.9K
Antiasthma Drugs: β2-Adrenoceptor Agonists01:25

Antiasthma Drugs: β2-Adrenoceptor Agonists

Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
1.6K